SHANGHAI, China, June 19 WuXi PharmaTech (Cayman)Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical deviceresearch and development outsourcing company with operations in China and theUnited States, today announced that it has posted its 2007 annual report onthe Investor Relations page of its website at http://www.wuxipharmatech.com .
(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )
The 2007 annual report includes a copy of the Company's Form 20-F for thefiscal year ended December 31, 2007, which was filed with the U.S. Securitiesand Exchange Commission on June 16, 2008.
Shareholders can receive a hard copy of the annual report free of chargeby sending a request through our website or by contacting our IRrepresentatives stated below.
About WuXi PharmaTech
WuXi PharmaTech is a leading pharmaceutical, biotechnology and medicaldevice R&D outsourcing company, with operations in China and the United States.As a research-driven and customer-focused company, WuXi PharmaTech providespharmaceutical, biotechnology and medical device companies a broad andintegrated portfolio of laboratory and manufacturing services throughout thedrug and medical device R&D process. WuXi PharmaTech's services are designedto assist its global partners in shortening the cycle and lowering the cost ofdrug and medical device R&D. For more information, please visit:http://www.wuxipharmatech.com .For more information, please contact: Investor Contact: Dr. Hai Mi, Vice President Corporate Communications WuXi PharmaTech (Cayman) Inc. Tel: +86-21-5046-3726 Email: [email protected]
Web: http://www.wuxipharmatech.com Investor Relations (US): Mahmoud Siddig, Director Taylor Rafferty Tel: +1-212-889-4350 Email: [email protected]
Web: http://www.taylor-rafferty.com Investor Relations (HK): Ruby Yim, Managing Director Taylor Rafferty Tel: +852-3196-3712 Email: [email protected]
Web: http://www.taylor-rafferty.com Media Contact: John Dudzinsky, Director Taylor Rafferty Tel: +1-212-889-4350 Email: [email protected]
SOURCE WuXi PharmaTech (Cayman) Inc.